Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-09-13
1997-06-17
Dees, JoseG.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, A61K 31445
Patent
active
056397585
ABSTRACT:
A method for the treatment of a cutaneous, ocular, or mucosal pathological condition which is associated with immune response in a human or other mammal, that includes topical application of an effective amount of spiperone or a spiperone derivative or its pharmaceutically acceptable salt, in a pharmaceutically-acceptable diluent or carrier for topical application.
REFERENCES:
patent: 2788309 (1957-04-01), Cooper
patent: 2854380 (1958-09-01), Jensen
patent: 3155669 (1964-11-01), Janssen et al.
patent: 3155670 (1964-11-01), Janssen et al.
patent: 3161644 (1964-12-01), Janssen et al.
patent: 3238216 (1966-03-01), Janssen et al.
patent: 3996363 (1976-12-01), Wade et al.
patent: 4839342 (1989-06-01), Kaswan
patent: 4874766 (1989-10-01), Ooms et al.
Blozyski, et al., Arch. Intern, Pharmacodynamie, 123, 58-66 (1959), Chemical Abstracts, 54, Abstract 215049-i (1960).
Burka, et al., "Dopaminergic (Co-Mediator) Modulation of Release of Histamine and SRS-A in the Calf," British Journal of Pharmacology, 58(3) 445 (1976).
Eyre, "Dopamine Potentiates Anaphylactic Contraction of Pulmonary Vein of Calf," Research Communications in Chemical Pathology and Pharmacology, 22(3) 447-453 (1978).
Levsen et al., "Receptor Binding of R 41 468, A Novel Antagonist at 5-HT2 Receptors," Life Sciences, 28(9) 1015-1022 (1981).
Moerlein et al, "Effect of Lipophilicity on the In Vivo Localization of Radiolabelled Spiperone Analogues", Int. J. Nucl. Med. Biol. 12, 353-56 (1985).
Nakanishi, M., et al., "Spirohydantion Derivataives," Chemical Abstracts vol. 75 (1971) 110315n.
Reynolds, "Martindale, The Extra Pharmacopoeia," The Pharmaceutical Press, London, 1989.
Arndt Kenneth A.
Galli Stephen J.
Sharpe Richard J.
Beth Israel Deaconess Medical Center Inc.
Cebulak Mary C.
Dees Jose'G.
Meredith Roy D.
LandOfFree
Topical application of spiperone or derivatives thereof for trea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical application of spiperone or derivatives thereof for trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical application of spiperone or derivatives thereof for trea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157967